Jazz Pharmaceuticals (JAZZ) Divestments (2015)
Jazz Pharmaceuticals (JAZZ) posted quarterly Divestments of $1.0 million for Q2 2015, down 96.97% quarter-over-quarter from $33.0 million in Q1 2015.
Jazz Pharmaceuticals (JAZZ) Divestments (2015) Analysis & Trends
Jazz Pharmaceuticals' Divestments history runs 1 years deep, the most recent figure standing at $1.0 million for Q2 2015.
- In Q2 2015, Divestments changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2016 stood at $1.0 million (down 96.97% YoY), while the FY2022 annual figure was $53.0 million, changed N/A from the prior year.
- Divestments for Q2 2015 stood at $1.0 million, down from $33.0 million in the prior quarter.
- The five-year high for Divestments was $33.0 million in Q1 2015, with the low at $1.0 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.00 Mn |
| Mar 31, 2015 | 33.00 Mn |